ADTX: Rega marang dodolan Aditxt Inc.

Aditxt diversification between the diagnostics and therapy of autoimmune pathologies defines the current trend, while the P/S history demonstrates that the value remains at 1017.10. This price action reflects the implementation of the AditxtScore system and the expansion of the laboratory network, however, patent protection and FDA requirements are offset by financial instability, creating a notable imbalance in the business's market value.

Aditxt's stable operations within the US domestic market and the humanitarian status of its developments minimize external risks, ensuring operational resilience. By analyzing the volatility of the P/S ratio, an investor assesses the relationship between market capitalization and revenue, which allows for determining the degree of overpayment for the asset relative to its actual sales and confirming the long-term fundamental stability of the quotes.